Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging

Giorgio Radetti1, Wolfgang Kleon, Joseph Stuefer

  • 1Department of Paediatrics, Regional Hospital of Bolzano, Italy. giorgio.radetti@asbz.it

Insights

Non-alcoholic fatty liver disease (NAFLD) is common in obese children, affecting 31.8%. Liver enzyme elevations correlate with fatty liver, but clinical factors do not predict NAFLD in this group.

Area of Science:

  • Pediatrics
  • Hepatology
  • Metabolic Disorders

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a growing concern in pediatric populations.
  • Obesity is a primary risk factor for NAFLD development and progression.

Purpose of the Study:

  • To determine the prevalence of NAFLD in obese children.
  • To explore correlations between hepatic steatosis severity, anthropometric data, and insulin resistance parameters.

Main Methods:

  • Study included 44 obese children (BMI > 97th percentile, aged 6-16).
  • Hepatic fat content assessed via phase contrast MRI.
  • Evaluated demographic data, blood tests (glucose, insulin, lipids), and insulin sensitivity (QUICKI).

Main Results:

  • NAFLD identified in 31.8% of subjects.
  • Children with NAFLD had higher ALT, AST, and triglyceride levels.
  • Liver fat infiltration correlated with ALT, AST, gammaGT, height, and BMI, but not body fat mass or distribution.

Conclusions:

  • Obese children frequently have NAFLD.
  • Clinical and anthropometric findings do not reliably predict NAFLD in this cohort.
  • A strong correlation exists between the degree of liver fat and elevated liver enzymes.
Abstract